Global Health Limited has announced that its earnings conference call for the fourth quarter ended March 31, 2026, has been scheduled for Friday, May 15, 2026, at 2:00 PM IST. The call will be hosted by ICICI Securities and is being conducted pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was filed by Company Secretary & Compliance Officer Rahul Ranjan on May 11, 2026.

Conference Call Details

The earnings call is open to investors and analysts across multiple geographies, with dedicated dial-in numbers available for international participants. The following table summarises the key logistics of the call:

Participants may also register in advance via the DiamondPass link provided by the company for a zero-wait-time connection experience.

Management Representatives

The senior management team scheduled to represent Global Health Limited on the call includes:

• Dr. Naresh Trehan – Chairman & Managing Director
• Mr. Pankaj Sahni – Group CEO & Director
• Mr. Yogesh Kumar Gupta – Chief Financial Officer
• Mr. Ravi Gothwal – Head, Investor Relations

About Global Health Limited (Medanta)

Global Health Limited operates under the "Medanta" brand and is described as one of the largest private multi-specialty tertiary care providers in the North and East regions of India, according to a report titled "An assessment of the healthcare delivery market in India, September 2022" by CRISIL Limited. The company was founded by Dr. Naresh Trehan, a cardiovascular and cardiothoracic surgeon who has been awarded the Padma Bhushan, the Padma Shri, and the Dr. B.C. Roy Award.

The company currently operates a network of six hospitals under the Medanta brand, located in Gurgaon, Indore, Ranchi, Lucknow, Patna, and Noida. Its operational hospitals span an area of 5.6 million sq.ft. and had 3,579 installed beds as on December 31, 2025. Global Health Limited also has five upcoming hospitals in Mumbai, Guwahati, Varanasi, and two hospitals in Delhi. The company provides healthcare services across over 30 medical specialties and engages over 2,300+ doctors.

Investor Contact Information

For further information regarding the conference call, investors may reach out through the following contacts:

Additional details of the earnings call are available on the company's website at www.medanta.org .

Global Health Limited has notified the stock exchanges of a forthcoming board meeting scheduled for Thursday, May 14, 2026. The intimation was filed on May 06, 2026, in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will address key financial and corporate governance matters pertaining to Financial Year 2025-26.

Agenda for the Board Meeting

The board meeting has been convened to deliberate on the following key items:

The dual agenda underscores the significance of the meeting, covering both the company's full-year financial performance disclosure and a potential return of value to shareholders.

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code for Prevention of Insider Trading, Global Health Limited has confirmed that the trading window for its securities is already closed effective April 01, 2026. The trading window will reopen 48 hours after the declaration of the aforementioned financial results.

The intimation was signed by Rahul Ranjan, Company Secretary & Compliance Officer (M. No. A17035), on behalf of Global Health Limited, and has been submitted to both BSE Limited and the National Stock Exchange of India Limited for their records.